China National Medicines Corporation Ltd.

SHSE:600511 Stok Raporu

Piyasa değeri: CN¥24.0b

China National Medicines Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 4/6

China National Medicines yıllık ortalama 9.1% oranında kazançlarını artırırken, Healthcare sektöründe kazançlar growing at 2% annual. Gelirler growing yılda ortalama 4% oranında artmaktadır. China National Medicines'in özkaynak karlılığı 12.6% ve net marjı 4.2%'dir.

Anahtar bilgiler

9.1%

Kazanç büyüme oranı

9.3%

EPS büyüme oranı

Healthcare Sektör Büyümesi7.0%
Gelir büyüme oranı4.0%
Özkaynak getirisi12.6%
Net Marj4.2%
Son Kazanç Güncellemesi30 Sep 2024

Yakın geçmiş performans güncellemeleri

Recent updates

The China National Medicines Corporation Ltd. (SHSE:600511) Third-Quarter Results Are Out And Analysts Have Published New Forecasts

Oct 25
The China National Medicines Corporation Ltd. (SHSE:600511) Third-Quarter Results Are Out And Analysts Have Published New Forecasts

China National Medicines Corporation Ltd.'s (SHSE:600511) Prospects Need A Boost To Lift Shares

Sep 26
China National Medicines Corporation Ltd.'s (SHSE:600511) Prospects Need A Boost To Lift Shares

Calculating The Fair Value Of China National Medicines Corporation Ltd. (SHSE:600511)

Sep 10
Calculating The Fair Value Of China National Medicines Corporation Ltd. (SHSE:600511)

Returns On Capital At China National Medicines (SHSE:600511) Paint A Concerning Picture

Jul 28
Returns On Capital At China National Medicines (SHSE:600511) Paint A Concerning Picture

China National Medicines Corporation Ltd.'s (SHSE:600511) Low P/E No Reason For Excitement

Jun 24
China National Medicines Corporation Ltd.'s (SHSE:600511) Low P/E No Reason For Excitement

China National Medicines (SHSE:600511) Has Announced That It Will Be Increasing Its Dividend To CN¥0.854

Jun 07
China National Medicines (SHSE:600511) Has Announced That It Will Be Increasing Its Dividend To CN¥0.854

Is China National Medicines (SHSE:600511) Using Too Much Debt?

Jun 05
Is China National Medicines (SHSE:600511) Using Too Much Debt?

Calculating The Fair Value Of China National Medicines Corporation Ltd. (SHSE:600511)

May 21
Calculating The Fair Value Of China National Medicines Corporation Ltd. (SHSE:600511)

Capital Allocation Trends At China National Medicines (SHSE:600511) Aren't Ideal

Apr 10
Capital Allocation Trends At China National Medicines (SHSE:600511) Aren't Ideal

China National Medicines (SHSE:600511) Could Easily Take On More Debt

Feb 28
China National Medicines (SHSE:600511) Could Easily Take On More Debt

Gelir ve Gider Dağılımı

China National Medicines nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

SHSE:600511 Gelir, gider ve kazançlar (CNY Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Sep 2451,1952,1651,33762
30 Jun 2450,3122,1621,35166
31 Mar 2450,5922,1911,41768
31 Dec 2349,6962,1461,43771
30 Sep 2347,4861,9951,41676
30 Jun 2347,6322,0861,47672
31 Mar 2345,6652,0051,42870
31 Dec 2245,4991,9641,38567
30 Sep 2246,7191,8841,41360
30 Jun 2246,3991,8501,38559
31 Mar 2247,1851,8301,39457
31 Dec 2146,4691,7541,39056
30 Sep 2145,5591,6801,39456
30 Jun 2144,9231,5291,43555
31 Mar 2142,5121,4491,44553
31 Dec 2040,3791,3831,41352
30 Sep 2041,0461,5371,42662
30 Jun 2041,1531,4691,41852
31 Mar 2042,8051,5491,41550
31 Dec 1944,6441,6041,48945
30 Sep 1942,6731,5251,44342
30 Jun 1940,9911,5231,41442
31 Mar 1939,6591,4361,42437
31 Dec 1838,7401,4041,45734
30 Sep 1837,9941,2561,42422
30 Jun 1837,4521,2241,36330
31 Mar 1836,6531,1631,17625
31 Dec 1736,2851,1411,00222
30 Sep 1736,0721,06091810
30 Jun 1735,5401,0448230
31 Mar 1740,1031,1019670
31 Dec 1634,6119908510
30 Sep 1628,6138876750
30 Jun 1622,8137525940
31 Mar 1612,4085273850
31 Dec 1512,0785133810
30 Sep 1512,0654994150
30 Jun 1511,8944993850
31 Mar 1511,7734903970
31 Dec 1411,5384833900
30 Sep 1411,1774653910
30 Jun 1410,8244573880
31 Mar 1410,4084313660
31 Dec 1310,0814123590

Kaliteli Kazançlar: 600511 yüksek kaliteli kazançlar sağlıyor.

Büyüyen Kar Marjı: 600511 'nin mevcut net kar marjları (4.2%) geçen yılın (4.2%) sinden daha yüksektir.


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: 600511 şirketinin kazancı son 5 yılda yılda 9.1% oranında arttı.

Büyüme Hızlandırma: 600511 'un son bir yıldaki kazanç büyümesi ( 8.5% ) 5 yıllık ortalamasının ( 9.1% /yıl) altındadır.

Kazançlar vs. Sektör: 600511 geçen yılki kazanç büyümesi ( 8.5% ) Healthcare sektörünün -5.7% değerini aştı.


Özkaynak Getirisi

Yüksek ROE: 600511 'nin Özsermaye Getirisi ( 12.6% ) düşük olarak değerlendiriliyor.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin